Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Learn about the critical role of molecular testing in chronic myeloid leukemia (CML) diagnosis and treatment through this 38-minute webinar presented by Prof. Simona Soverini, Associate Professor of Hematology at the University of Bologna and head of the Myeloid Leukemia Research group. Explore how CML serves as a paradigm of precision medicine, being the first human malignancy whose molecular pathogenesis was fully understood before the advent of omics technologies and the first to successfully implement molecularly targeted therapies. Discover the essential molecular testing strategies that guide clinical decision-making in CML management, from initial diagnosis through treatment monitoring. Gain insights into the latest developments in molecular diagnostics and their practical applications in optimizing patient outcomes. Understand the scientific foundations that established CML as a model for precision oncology and how molecular testing continues to shape therapeutic approaches in this hematologic malignancy.
